Brief: Atossa Therapeutics - On October 2, Greg Weaver Provided Notice Of His Resignation As Executive Vice President And CFO
06/10/2023 21:43
Oct 6 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS - ON OCTOBER 2, GREG WEAVER PROVIDED
NOTICE
OF HIS RESIGNATION AS EXECUTIVE VICE PRESIDENT AND CFO
* ATOSSA THERAPEUTICS - APPOINTED HEATHER REES AS COMPANY'S
PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
Further company coverage: ATOS.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary